State Board of Administration of Florida Retirement System’s Navidea Biopharmaceuticals Inc. NAVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-3,003
Closed -$57K 2403
2016
Q1
$57K Hold
3,003
﹤0.01% 2373
2015
Q4
$80K Hold
3,003
﹤0.01% 2409
2015
Q3
$137K Hold
3,003
﹤0.01% 2333
2015
Q2
$97K Hold
3,003
﹤0.01% 2405
2015
Q1
$96K Hold
3,003
﹤0.01% 2425
2014
Q4
$114K Hold
3,003
﹤0.01% 2443
2014
Q3
$79K Hold
3,003
﹤0.01% 2471
2014
Q2
$89K Hold
3,003
﹤0.01% 2495
2014
Q1
$111K Hold
3,003
﹤0.01% 2427
2013
Q4
$124K Hold
3,003
﹤0.01% 2444
2013
Q3
$159K Hold
3,003
﹤0.01% 2427
2013
Q2
$160K Buy
+3,003
New +$150K ﹤0.01% 2435

Other funds holding NAVB

State Board of Administration of Florida Retirement System's NAVB Position: Q2 2016 in Review

State Board of Administration of Florida Retirement System sold out of Navidea Biopharmaceuticals Inc. (NAVB) in Q2 2016, closing a stake of 3,003 shares — an estimated $57K sold.

State Board of Administration of Florida Retirement System first reported a position in NAVB in Q2 2013 and held it in 12 quarters. The position peaked at $160K in Q2 2013. 63 funds tracked by Wall St. Rank hold NAVB as of Q2 2016.

  • State Board of Administration of Florida Retirement System reported no remaining Navidea Biopharmaceuticals Inc. position as of Q2 2016 after selling out during the quarter.
  • State Board of Administration of Florida Retirement System sold 3,003 Navidea Biopharmaceuticals Inc. shares in Q2 2016, an estimated $57K.
  • State Board of Administration of Florida Retirement System first reported a position in Navidea Biopharmaceuticals Inc. in Q2 2013 and held it in 12 quarters.
  • State Board of Administration of Florida Retirement System's Navidea Biopharmaceuticals Inc. position peaked at $160K in Q2 2013.
  • 63 funds tracked by Wall St. Rank held Navidea Biopharmaceuticals Inc. as of Q2 2016.

Based on State Board of Administration of Florida Retirement System's 13F filing for Q2 2016, filed 4 Aug 2016.